A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer.

Patrick M BolandJohn M L EbosKristopher AttwoodMichalis MastriChristos FountzilasRenuka V IyerChristopher BankerAndrew K L GoeyRobert BiesWen Wee MaMarwan G Fakih

Published in: JNCI cancer spectrum (2024)

NCT02393755.

Keyphrases

metastatic colorectal cancer
clinical trial
rheumatoid arthritis
squamous cell carcinoma
radiation therapy
systemic sclerosis
metastatic breast cancer